(Q46490963)

22 December 2017

title

Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women (English)

1 reference

22 December 2017

1 reference

Giancarlo Garuti

1

1 reference

22 December 2017

Fulvia Cellani

2

1 reference

22 December 2017

Giovanna Centinaio

3

1 reference

22 December 2017

Giulia Sita

4

1 reference

22 December 2017

Giulio Nalli

5

1 reference

22 December 2017

Massimo Luerti

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

22 December 2017

published in

Gynecologic Oncology

1 reference

22 December 2017

volume

98

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

63-67

1 reference

22 December 2017

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Endometrial changes in patients on tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

The effects of tamoxifen treatment on the endometrium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Risk of endometrial cancer after tamoxifen treatment of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Overview of the main outcomes in breast-cancer prevention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Longitudinal hysteroscopic follow-up during tamoxifen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Hysteroscopic evaluation of the endometrium of post-menopausal patients with breast cancer before and after tamoxifen use

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Uterine side effects of tamoxifen: a need for systematic pretreatment screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Guidelines for monitoring patients taking tamoxifen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Endometrial morphology in asymptomatic postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Tamoxifen and endometrial pathologies: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.03.036

10.1016/J.YGYNO.2005.03.036

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

release_4dmdulhxdjahfnbrl6iziwahvy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4dmdulhxdjahfnbrl6iziwahvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15894357

1 reference

22 December 2017